Research
November 15 2021
2021-11-15
AEMPS authorizes Phase IIb clinical trial of HIPRA Covid-19 vaccine
The biotechnological pharmaceutical company HIPRA has received authorization from the Spanish Agencyfor Medicines and Health Products (AEMPS) to sta1